DIN 02532476 — SUNLENCA 309 MG
SUNLENCA is a solution of Lenacapavir marketed by GILEAD SCIENCES CANADA INC. The full Lenacapavir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02532476
- Brand name
- SUNLENCA
- Active ingredient
- Lenacapavir
- Strength
- 309 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- GILEAD SCIENCES CANADA INC
- Health Canada status
- MARKETED
- Drug class
- HIV-1 capsid inhibitor (antiretroviral agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.